Medicine recalls
|
| |
| The United States: Salud Natural Entrepreneur Inc. recalls Nopalina Flax Seed Fiber Powder and Nopalina Flax Seed Fiber Capsules because of possible health risk |
| |
The US Food and Drug Administration (FDA) announces that Salud Natural Entrepreneur Inc. of Waukegan, IL is voluntarily recalling Nopalina Flax Seed Fiber (powder) and Nopalina Flax Seed Fiber (capsule) products due to possible Salmonella contamination in one of the ingredients used on the formula of Nopalina Flax Seed Fiber.
Salmonella is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis. Consumers of these products who are experiencing symptoms of Salmonella should contact their health care provider. To date, there are no reports of illnesses associated with the products.
Nopalina Flax Seed products are distributed throughout the United States and Puerto Rico via retail stores and the company’s web site. For details of the affected products and lot numbers, please refer to the website in FDA.
The recall is the result of an FDA sampling of senna leaves powder, an ingredient used to manufacture the Nopalina Flax Seed Fiber (powder) and Nopalina Flax Seed Fiber (capsules), that tested positive for three types of Salmonella including Salmonella Gaminara, Salmonella Kentucky, and Salmonella Oranienburg. The company has ceased the use of the suspect ingredient.
Please refer to the following website in FDA for details:
http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/salud-natural-entrepreneur-inc-recalls-nopalina-flax-seed-fiber-powder-and-nopalina-flax-seed-fiber-0
In Hong Kong, the above products are not registered pharmaceutical products. There is also no registered pharmaceutical product manufactured by the above company.
Ends/Tuesday, Feb 4, 2020
Issued at HKT 15:00
|
| |
